DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 117 filers reported holding DYNE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $19,891,505 | 30.79% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $44,363,675 | 23.76% |
| Atlas Venture Life Science Advisors, LLC | 9,885,449 | $88,573,623 | 13.72% |
| Logos Global Management LP | 2,180,000 | $19,532,800 | 2.61% |
| TCG Crossover Management, LLC | 1,650,150 | $14,785,344 | 2.18% |
| VR Adviser, LLC | 2,173,913 | $19,478,260 | 2.05% |
| Altium Capital Management LP | 315,000 | $2,822,400 | 1.47% |
| Vivo Capital, LLC | 1,035,136 | $9,274,819 | 1.02% |
| Octagon Capital Advisors LP | 692,945 | $6,208,787 | 0.95% |
| ACUTA CAPITAL PARTNERS, LLC | 146,500 | $1,312,640 | 0.88% |
| Deep Track Capital, LP | 2,403,672 | $21,536,901 | 0.83% |
| Nantahala Capital Management | 683,164 | $6,121,149 | 0.52% |
| BRAIDWELL LP | 1,821,972 | $16,324,869 | 0.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 137,751 | $1,231,494 | 0.42% |
| Sofinnova Investments, Inc. | 685,133 | $6,138,792 | 0.39% |
| Artal Group S.A. | 815,085 | $7,303 | 0.31% |
| Ikarian Capital, LLC | 2,726 | $2,442,496 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,200,000 | $10,752,000 | 0.16% |
| WASATCH ADVISORS LP | 1,687,802 | $15,122,706 | 0.10% |
| Corton Capital Inc. | 19,926 | $178,537 | 0.09% |
External links
This page lists DYNE THERAPEUTICS INC's shareholders in Q3 2023. To view DYNE THERAPEUTICS INC's shareholder history, click here.